John Nevelow
Optometrist · San Antonio, TXNPI 1710984067
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (58.6%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 13 manufacturers reported payments, led by Alcon at 45.2% of the total. 2025 is the largest year on record at $1,667, 3.7 times the $451 reported in 2019.
Across 31 payments — averaging $112.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$2K
- Biotissue Holdings Inc.$521
- Glaukos Corporation$407
- Dompe US, Inc.$150
- Novartis$127
- Amgen$125
- plus $584 from 7 others
What the payments were for
- Consulting fees$3009%
- Travel & lodging$1,14533%
- Food & beverage$2,04759%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 7 | $1,579 |
| Biotissue Holdings Inc. | 6 | $521 |
| Glaukos Corporation | 3 | $407 |
| Dompe US, Inc. | 2 | $150 |
| Novartis | 3 | $127 |
| Amgen | 1 | $125 |
| Aerie Pharmaceuticals, Inc. | 1 | $123 |
| Bausch & Lomb Americas Inc. | 2 | $117 |
| Oyster Point Pharma, Inc. | 1 | $111 |
| Rxsight Inc | 2 | $97 |
| Johnson & Johnson Surgical Vision, Inc. | 1 | $88 |
| Sight Sciences, Inc. | 1 | $32 |
| Sun Pharmaceutical Industries Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Prokera$261
- AmnioGraft$261
- TEPEZZA$125
- Rhopressa$123
- Rocklatan$123
- Oxervate$122
- TYRVAYA$111
- XIIDRA$109
- Precision 1$102
How this compares
$3,492 in reported general payments places this provider in the 85th percentile of 4,315 optometrist providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LumiganBimatoprost | 16 | $10,194 |
| Latanoprost | 29 | $122 |
Paid to pharmacies, not to this prescriber.
Other optometrist in San Antonio
- Carolyn MajcherSan Antonio$86K
- Chandler MannSan Antonio$49K
- Jeff FosterSan Antonio$31K
- Melanie FrogozoSan Antonio$21K
- Edward BustamanteSan Antonio$21K
- Arthur MedinaSan Antonio$20K
- Derek CunninghamAustin$940K
- Claudio LagunasHouston$644K
- Ashley Wallace-TuckerHouston$547K
- Luis RojasMcKinney$309K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.